Showing 311-320 of 7487 results for "".
Attention, Please! Why Dermatologists Need to Confront Burnout
https://practicaldermatology.com/topics/practice-management/attention-please-why-dermatologists-need-to-confront-burnout/20557/Raising awareness of the problem is essential to finding a solution.How Much Are You Paying Your Advisor?
https://practicaldermatology.com/topics/practice-management/how-much-are-you-paying-your-advisor/20609/A guide to understanding advisor fees and other charges.Updates from ASDS 2017
https://practicaldermatology.com/series/dermwire-tv/updates-from-asds-2017/18411/From microneedling to skin redraping to body contouring, the Annual Meeting of the American Society for Dermatologic Surgery (ASDS) brings cosmetic and surgical dermatology into focus. With an emphasis on the state of the art in dermatologic procedures, the annual meeting of the ASDS gathered hundreStanding Apart: The Personal Touch
https://practicaldermatology.com/topics/practice-management/standing-apart-the-personal-touch/18437/Many dermatology practices exist in a crowded market place. How can they set themselves apart? Focus on the personal touch, says Gary Goldenberg, MD of Goldenberg Dermatology.Re-introducing Ortho Dermatologics, Tremfya Approved, Obagi Acquired
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-re-introducing-ortho-dermatologics-tremfya-approved-obagi-acquired/18458/Valeant Pharmaceuticals is changing the name of its dermatology division to Ortho Dermatologics. In an exclusive interview with DermWireTV, Executive Vice President and dermatology industry veteran William Bill Humphries discusses the change. The FDA has approved Janssen Biotech's Tremfya (guselkumaRevance Data, AD Updates, FDA Actions
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-revance-data-ad-updates-fda-actions/18463/A US District Court judge blocks Stratus Pharmaceuticals of Miami and Sonar Products of Carlstadt, NJ from selling substandard dermatological products. Newly identified mutations in a gene called CARD11 may lead to atopic dermatitis. Surprising new evidence suggests atopic dermatitis is associated wGolden Achievement: Dr. Michael Gold on Lifetime Award at CSF 2016
https://practicaldermatology.com/topics/practice-management/golden-achievement-dr-michael-gold-on-lifetime-award-at-csf-2016/18712/Michael H. Gold, MD was recognized December 2016 at the Cosmetic Surgery Forum in Las Vegas with the Lifetime Contribution to Aesthetics Award by CSF Founder Joel Schlessinger, MD. Speaking about the award, Dr. Gold shares his perspective as a global educator and practitioner (Dr. Gold cofounded theLasers in Acne: Expanding the Options
https://practicaldermatology.com/topics/general-topics/lasers-in-acne-expanding-the-options/18745/By Abigail Waldman, MD and Seemal R. Desai, MDThe Nd-YAG (1064nm) laser can be used for acne—including cystic acne—and acne scarring. Dr. Waldman discusses the AAD's first-ever hands-on laser session and the role of the Nd-YAG laser in patient care.Meaningful Approaches to Vitiligo
https://practicaldermatology.com/topics/general-topics/meaningful-approaches-to-vitiligo/18599/As science continues to uncover more about vitiligo and its treatment, dermatologists have more options than ever. But there's still work to be done. In this edition of Ask an Expert, host Adam Friedman, MD talks to John E. Harris, MD, PhD, Director of the Vitiligo Clinic and Research Center at UnivAdvances in Laser Tattoo Removal
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/advances-in-laser-tattoo-removal/18607/Laser tattoo removal continues to rise in popularity largely due to advances in technology and technique. In particular, the DeScribe Transparent PFD Patch has helped make tattoo removal treatment sessions more tolerable for patients and expedite clearance of tattoos. Jeremy A. Brauer, MD Director o